VANCOUVER, BC / ACCESSWIRE / June 30, 2020 / Canland Health Corp. (formerly, 1155176 B.C. Ltd.) (the “Company”) announces that due to ongoing non-essential business shut down for COVID-19 measures taken by the Province of British Columbia, is exempt from Group A filings and delaying its annual financial statements release and filing on SEDAR until August 13, 2020 (45 day extension).
As required under section 4.2 of BC Instrument 51-515, the Company provides the following updates and information for investors:
About Canland Health Corp.
Canland Health Corp. is in the business of venture capital and investment in the Canadian healthcare sector.
For further information please contact:
Jacky Fu, CFO and director
E-mail: jfu@canlandhc.com
Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based on are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
SOURCE: Canland Health Corp.
View source version on accesswire.com:
https://www.accesswire.com/595756/Canland-Health-Corp-Announces-Extension-of-Filing-Its-Annual-Report-Due-to-COVID-19
TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…
Afrezza® Afrezza® (insulin human) Inhalation Powder. Study proves inhaled insulin is as effective as usual…
PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader…
TERN-501 significantly improved the efficacy of a GLP-1 receptor agonist by normalizing energy expenditure, resulting…
MINNEAPOLIS, June 21, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the…
Shrivers Hospice sets a benchmark for quality care in Ohio with prestigious award LOS ANGELES,…